Screener
Haemonetics HAE Other, net
Other, net at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Proceeds from employee stock purchase plan | 3,123 | 3,476 |
| Proceeds from exercise of stock options | 426 | 462 |
| Cash used to net share settle employee equity awards | (3,500) | (4,781) |
| Other financing activities | (14) | (36) |
| Net cash used in financing activities | (51,528) | (2,442) |
| Effect of exchange rates on cash and cash equivalents | (617) | 4,182 |
| Net Change in Cash and Cash Equivalents | (22,056) | (13,865) |
| Cash and Cash Equivalents at Beginning of Period | 245,440 | 306,763 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's other, net?
- Haemonetics (HAE) reported other, net of -$14K in Q2 2026.
- How has Haemonetics's other, net changed year-over-year?
- Haemonetics's other, net increased by 61.1% year-over-year, from -$36K to -$14K.
- What is the long-term trend for Haemonetics's other, net?
- Over 3 years (2023 to 2026), Haemonetics's other, net has grown at a 32.3% compound annual growth rate (CAGR), from -$44K to -$102K.
- What does other, net mean?
- Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.
Ask your AI about Haemonetics's other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude